OXY Stock Cash Flow Statements

Occidental Petroleum Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Free Cash Flow

Capital Expenditure

Occidental Petroleum Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2010-12-31

cash flow from operating activities
net income	468,000,000	945,000,000	-120,000,000	1,140,000,000	1,170,000,000	888,000,000	1,198,000,000	1,375,000,000	860,000,000	1,263,000,000	1,927,000,000	2,746,000,000	3,755,000,000	4,876,000,000	1,537,000,000	828,000,000	103,000,000	-146,000,000	-1,112,000,000	-3,575,000,000	-8,131,000,000	-2,013,000,000	-1,036,000,000	1,226,000,000
adjustments to reconcile net income to net cash from operating activities:
discontinued operations			0	0	0	-182,000,000									24,000,000	2,000,000	-3,000,000	445,000,000	-37,000,000	-80,000,000			0	21,000,000
depreciation, depletion and amortization of assets	1,936,000,000	1,917,000,000	1,977,000,000	1,926,000,000	1,775,000,000	1,693,000,000	1,723,000,000	1,712,000,000	1,709,000,000	1,721,000,000	1,819,000,000	1,736,000,000	1,728,000,000	1,643,000,000	1,966,000,000	1,916,000,000	2,371,000,000	2,194,000,000	1,754,000,000	1,915,000,000	2,186,000,000	2,242,000,000	2,271,000,000	545,000,000
deferred income tax benefit	-17,000,000	-129,000,000										272,000,000	203,000,000	-2,240,000,000		20,000,000	-131,000,000	-81,000,000	-400,000,000	-374,000,000	-1,525,000,000	-218,000,000
gain on sales of assets and other
other noncash charges to income	235,000,000	267,000,000																	285,000,000				362,000,000	461,000,000
changes in operating assets and liabilities:
increase in trade receivables	140,000,000	-85,000,000
increase in inventories	292,000,000	-49,000,000	180,000,000	561,000,000	-677,000,000	-110,000,000	-47,000,000	31,000,000	173,000,000	-248,000,000	-134,000,000											-70,000,000
decrease in other current assets
increase in accounts payable and accrued liabilities											337,000,000	-1,586,000,000			272,000,000	118,000,000
increase in current domestic and foreign income taxes	-258,000,000	20,000,000	47,000,000	305,000,000	12,000,000	195,000,000	-86,000,000	178,000,000	-118,000,000	251,000,000	-80,000,000	-432,000,000	122,000,000	205,000,000				25,000,000			17,000,000	48,000,000
net cash from operating activities	2,960,000,000	2,148,000,000	3,356,000,000	3,682,000,000	2,394,000,000	2,007,000,000	3,239,000,000	3,129,000,000	3,070,000,000	2,870,000,000	3,975,000,000	4,267,000,000	5,329,000,000	3,239,000,000	3,092,000,000	3,118,000,000	3,314,000,000	910,000,000	1,404,000,000	852,000,000	360,000,000	1,339,000,000	2,009,000,000	2,742,000,000
cash flow from investing activities
capital expenditures	-1,998,000,000	-1,908,000,000	-1,781,000,000	-1,683,000,000	-1,771,000,000	-1,783,000,000	-1,544,000,000	-1,619,000,000	-1,646,000,000	-1,461,000,000	-1,520,000,000	-1,147,000,000	-972,000,000	-858,000,000	-937,000,000	-656,000,000	-698,000,000	-579,000,000	-614,000,000	-246,000,000	-382,000,000	-1,293,000,000
free cash flows	962,000,000	240,000,000	1,575,000,000	1,999,000,000	623,000,000	224,000,000	1,695,000,000	1,510,000,000	1,424,000,000	1,409,000,000	2,455,000,000	3,120,000,000	4,357,000,000	2,381,000,000	2,155,000,000	2,462,000,000	2,616,000,000	331,000,000	790,000,000	606,000,000	-22,000,000	46,000,000
change in capital accrual	-12,000,000	5,000,000	135,000,000	-15,000,000	-75,000,000	51,000,000	73,000,000	-53,000,000	25,000,000	-20,000,000	145,000,000	70,000,000	-29,000,000	-39,000,000	180,000,000	11,000,000	-19,000,000	-75,000,000	206,000,000	17,000,000	-307,000,000	-435,000,000
purchases of assets, businesses and equity investments	-56,000,000	-52,000,000	-92,000,000
proceeds from sales of assets						98,000,000		325,000,000	26,000,000	54,000,000		238,000,000	57,000,000	267,000,000
equity investments and other	-77,000,000	-82,000,000	-63,000,000	-85,000,000	-30,000,000	-34,000,000	-48,000,000	-47,000,000	-355,000,000	-20,000,000	-21,000,000	-23,000,000	-69,000,000	-3,000,000	427,000,000	6,000,000	-17,000,000	-10,000,000	-79,000,000	-15,000,000	61,000,000	142,000,000		65,000,000
net cash used by investing activities	-1,999,000,000	-731,000,000	-1,790,000,000	-9,119,000,000	-1,871,000,000	-1,810,000,000	-1,969,000,000	-1,474,000,000	-1,939,000,000	-1,598,000,000	-1,898,000,000	-1,019,000,000	-1,293,000,000	-662,000,000	-51,000,000	-166,000,000	-754,000,000	-282,000,000	1,579,000,000	-292,000,000	-576,000,000	-1,530,000,000
cash flow from financing activities
payments of long-term debt	-1,762,000,000	-518,000,000	-507,000,000				0	0	0	-22,000,000	-1,159,000,000	-1,217,000,000	-3,849,000,000	-3,259,000,000		-4,381,000,000	0	-174,000,000
proceeds from issuance of common stock	906,000,000	25,000,000	13,000,000	67,000,000	416,000,000	88,000,000	43,000,000	55,000,000	7,000,000	30,000,000	2,000,000	174,000,000	90,000,000	27,000,000		13,000,000	5,000,000	6,000,000			18,000,000	90,000,000		3,000,000
purchases of treasury stock			-18,000,000	0			-187,000,000	-434,000,000	-445,000,000	-732,000,000	-632,000,000	-1,899,000,000	-532,000,000	-36,000,000				-3,000,000	-8,000,000	0
cash dividends paid on common and preferred stock	-398,000,000	-380,000,000	-377,000,000	-371,000,000	-366,000,000	-332,000,000	-330,000,000	-347,000,000	-368,000,000	-320,000,000	-321,000,000	-324,000,000	-323,000,000	-216,000,000	-209,000,000	-210,000,000	-209,000,000	-211,000,000	-211,000,000
contributions from noncontrolling interest	51,000,000	63,000,000	54,000,000
other financing	-40,000,000	-122,000,000	-152,000,000	90,000,000	-44,000,000	-141,000,000	-35,000,000	-134,000,000	-28,000,000	-36,000,000	-48,000,000	-25,000,000	-33,000,000	-24,000,000	-32,000,000	-18,000,000	-15,000,000	-15,000,000	-320,000,000	-39,000,000	136,000,000	-196,000,000	264,000,000
net cash used by financing activities	-1,243,000,000	-932,000,000			39,000,000	-328,000,000	-455,000,000	-1,539,000,000	-1,816,000,000	-1,080,000,000	-2,330,000,000	-3,370,000,000	-4,586,000,000	-3,429,000,000		-5,424,000,000	-262,000,000	-354,000,000			-935,000,000	-1,019,000,000
increase in cash, cash equivalents, restricted cash and restricted cash equivalents	-282,000,000	485,000,000	364,000,000	-102,000,000	562,000,000	-131,000,000				192,000,000	-253,000,000	-122,000,000	-550,000,000	-852,000,000	509,000,000	-2,472,000,000	2,298,000,000	274,000,000	120,000,000				-1,791,000,000
cash, cash equivalents, restricted cash and restricted cash equivalents — beginning of period	0	2,157,000,000		0	0	1,464,000,000		0	0	1,026,000,000		0	0	2,803,000,000		0	0	2,194,000,000		0	0	3,574,000,000
cash, cash equivalents, restricted cash and restricted cash equivalents — end of period	-282,000,000	2,642,000,000		-102,000,000	562,000,000	1,333,000,000		116,000,000	-685,000,000	1,218,000,000		-122,000,000	-550,000,000	1,951,000,000		-2,472,000,000	2,298,000,000	2,468,000,000		861,000,000	-1,151,000,000	2,364,000,000
the accompanying notes are an integral part of these consolidated condensed financial statements.
millions	0	2,025,000,000		0	0	2,024,000,000
increase in other current assets		-52,000,000		73,000,000	140,000,000	6,000,000	354,000,000	-20,000,000	-225,000,000	-122,000,000	-22,000,000	-325,000,000	170,000,000	-158,000,000	53,000,000	-67,000,000	-23,000,000	-82,000,000
decrease in accounts payable and accrued liabilities		-686,000,000	-231,000,000			-454,000,000				-1,174,000,000				-187,000,000								-4,401,000,000
proceeds from sales of assets and equity investments		1,306,000,000
deferred income tax provision			-279,000,000	-47,000,000	-44,000,000	-91,000,000	-91,000,000	50,000,000	81,000,000	17,000,000														170,000,000
other noncash charges (benefit) to income
asset impairments and related items
losses (gains) on sales of assets and other
undistributed losses (earnings) from equity investments
dry hole expense
increase in joint interest receivables and other current assets
operating cash flow from continuing operations			3,556,000,000								3,975,000,000	4,267,000,000	5,329,000,000	3,239,000,000	3,231,000,000	2,910,000,000	3,324,000,000	788,000,000	1,367,000,000	815,000,000	436,000,000	1,224,000,000		2,459,000,000
operating cash flow from discontinued operations
proceeds from sale of assets and equity investments																						112,000,000	1,334,000,000
draws on receivables securitization facility							0				0	0
payment of receivables securitization facility							0				0	0
proceeds from long-term debt			0
redemption of preferred stock							0	-679,000,000
financing portion of net cash paid for derivative instruments																				-10,000,000
deferred payments for purchases of assets and businesses
net cash provided (used) by financing activities			-1,202,000,000
cash, cash equivalents, restricted cash and restricted cash equivalents — beginning of year
cash, cash equivalents, restricted cash and restricted cash equivalents — end of year
oxy 2024 form 10-k
asset impairments and other charges								0							131,000,000	17,000,000	21,000,000	135,000,000
(gains) losses on sales of assets
noncash charges to income and other						138,000,000			-207,000,000	156,000,000
increase in receivables				170,000,000	-626,000,000	-76,000,000					-235,000,000	2,293,000,000	-917,000,000	-1,238,000,000	-720,000,000	-187,000,000	-242,000,000	-937,000,000				3,909,000,000
operating cash flow from discontinued operations, net of taxes															-139,000,000	208,000,000	-10,000,000	122,000,000	37,000,000	37,000,000	-76,000,000	115,000,000
payment for taxes related to stock-based award settlement
gains on sales of assets								-192,000,000	-1,000,000	-4,000,000
noncash charges (benefits) to income and other
purchases of assets and equity investments
proceeds from sales of businesses and assets
contribution from noncontrolling interest					42,000,000	57,000,000
purchases of businesses and assets						-142,000,000		-80,000,000	11,000,000	-151,000,000		-157,000,000	-280,000,000	-29,000,000		-9,000,000	-8,000,000	-105,000,000
purchase of businesses, assets and equity investments
investing cash flow from continuing operations											-1,898,000,000	-1,019,000,000	-1,293,000,000	-662,000,000	-20,000,000	-146,000,000	-735,000,000	-273,000,000	1,589,000,000	-286,000,000	-572,000,000	-1,509,000,000
investing cash flow from discontinued operations															-31,000,000	-20,000,000	-19,000,000	-9,000,000
debt issuance costs
financing cash flow from continuing operations											-2,330,000,000	-3,370,000,000	-4,586,000,000	-3,429,000,000	-2,531,000,000	-5,422,000,000	-259,000,000	-352,000,000	-2,861,000,000	303,000,000
financing cash flow from discontinued operations															-1,000,000	-2,000,000	-3,000,000	-2,000,000
oxy 2023 form 10-k
noncash charges (benefit) to income and other
decrease in receivables
financing portion of net cash received for derivative instruments													61,000,000	79,000,000
decrease in cash, cash equivalents, restricted cash and restricted cash equivalents								116,000,000													-1,151,000,000	-1,210,000,000
decrease (increase) in receivables										1,010,000,000
(gain) loss on sales of equity investments and other assets
undistributed earnings from affiliates
payment of liabilities associated with the sale of future royalties
gain on sales of assets												-74,000,000	-23,000,000	-135,000,000
other noncash reconciling items												20,000,000	-515,000,000	34,000,000		189,000,000
financing portion of net cash received (paid) for derivative instruments																	-43,000,000	45,000,000
decrease in inventories
decrease (increase) in inventories														439,000,000
purchase of businesses and assets																			-12,000,000	-54,000,000	-13,000,000	-35,000,000
proceeds from long-term debt, net - occidental
payments of long-term debt, net - occidental
proceeds from long-term debt, net - wes
proceeds from issuance of common and preferred stock																			8,000,000				18,000,000
distributions to noncontrolling interest
oxy 2021 form 10-k
(gains) losses on sales of equity investments and other assets
increase in inventory
increase in current domestic and international income taxes																45,000,000
proceeds from sales of other assets and equity investments
proceeds from long-term debt, net of issuance costs
gains on sales of equity investments and other assets																	-3,000,000	-111,000,000
decrease in inventory
proceeds from sales of equity investments and other assets																	7,000,000	496,000,000
other noncash benefits to income																		-301,000,000
(increase) in inventory																		-311,000,000
(decrease) in accounts payable and accrued liabilities																		-42,000,000
other operating
asset impairments and other items																				2,695,000,000	6,452,000,000	1,768,000,000
losses (gains) on sales of assets
changes in operating assets and liabilities
proceeds from sale of assets																				12,000,000
investing cash flow from discontinued operations, net of taxes																				-6,000,000	-4,000,000	-21,000,000
proceeds from short-term borrowings and revolvers - wes
payment of revolvers - wes
distributions paid to noncontrolling interest
financing cash flow from discontinued operations, net of taxes																				-2,000,000
net cash (used) provided by financing activities
supplemental non-cash activities:
non-cash investing activities
exchange equity investment in wes
non-cash financing activities
settlement of long-term debt - wes
other noncash (gains) charges to income																					467,000,000	-550,000,000
decrease (increase) in other current assets																					-132,000,000	324,000,000
preferred stock issuance costs
cash dividends paid																					-714,000,000	-913,000,000
gain on sales of equity investments and other assets																						-7,000,000
undistributed losses (income) from affiliates																						174,000,000
dry hole expenses																						18,000,000
payments of long-term debt, net - wes
cash and cash equivalents — beginning of year
gain on sale of assets
cash from operating activities - continuing operations
cash used by operating activities - discontinued operations
cash used by investing activities - continuing operations
cash used by investing activities - discontinued operations
proceeds from wes revolvers
cash dividends paid to common stockholders
cash provided (used) by financing activities - continuing operations
cash used by financing activities - discontinued operations
net cash from (used) by financing activities
cash and cash equivalents — beginning of period
undistributed earnings from equity investments
payments for purchases of assets and businesses
sales of assets
purchase of treasury stock
decrease in cash and cash equivalents
cash and cash equivalents — end of period
adjustments to reconcile net income to net cash provided byoperating activities:
other noncash charges (benefits) to income
income from discontinued operations
sales of equity investments and assets
other
increase in cash, cash equivalents, and restricted cash
cash, cash equivalents, and restricted cash — beginning of year
cash and cash equivalents — end of year
increase in cash and cash equivalents																								475,000,000
net distributions from equity investments
other investing
gain on sale of equity investments and other assets
change in restricted cash
payment of long-term debt
adjustments to reconcile income to net cash provided byoperating activities:
the accompanying notes are an integral part of these consolidated financial statements.
special cash distributions from california resources
asset impairments
(gain) loss on sale of assets
sale of assets
net cash from financing activities
purchases of assets
purchase of businesses and other assets
proceeds from short-term borrowings
net cash provided (used by) financing activities
loss on sale of assets
cash and cash equivalents—beginning of period
cash and cash equivalents—end of period
gain on sale of equity investments
gain on sale of assets and equity investments
sale of assets and equity investments
purchases of long-term debt
contributions from (distributions to) noncontrolling interest
gain on sale of equity investment
sale of equity investment
gains on disposition of assets
dry hole and impairment expense																								15,000,000
adjustments to reconcile net income to net cash from operating activities
decrease (increase) in prepaid expenses and other assets
(gains) losses on disposition of assets
excess share-based tax benefits and other																								17,000,000
income from equity investments
sales of equity investments and available-for-sale investments
adjustments to reconcile net income to net cash provided by
operating activities:
losses (gains) on disposition of assets
excess share-based tax benefits
purchases of short-term investments
sales of short-term investments
depreciation, depletion and amortization expense
other non-cash charges to income
sales of investments
equity investments and other investing
excess tax benefits related to share-based payments
stock options exercised
decrease (increase) in accounts and notes receivable
decrease in current domestic and foreign income taxes
payments of long-term debt and capital lease liabilities
gain on disposition of assets
sale of businesses and disposal of property, plant, and equipment
short term investments - purchases
short term investments - sales
sale of equity investments and available-for-sale investments
payments of long-term debt and notes payable
the accompanying notes are an integral part of these financial statements.
adjustments to reconcile net income to net cash from operating
activities:
sales of businesses and disposal of property, plant, and equipment
cumulative effect of changes in accounting principles
reversal of tax reserves
gain on lyondell stock issuance
increase in accounts and notes receivable
increase in prepaid expenses and other assets
sale of businesses and disposal of property, plant and equipment
purchase of businesses
purchase of short-term investments
sale of short-term investments
repurchase of trust preferred securities
adjustments to reconcile income to net cash from operating activities:
payments on long-term debt and capital lease liabilities
income from continuing operations
purchase of businesses and other interests
sales of businesses and disposal of property, plant and equipment
redemption of trust preferred securities

We provide you with 20 years of cash flow statements for Occidental Petroleum stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Occidental Petroleum stock. Explore the full financial landscape of Occidental Petroleum stock with our expertly curated income statements.

The information provided in this report about Occidental Petroleum stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.